BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9217261)

  • 1. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
    Hohenester E; Hutchinson WL; Pepys MB; Wood SP
    J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.
    Aquilina JA; Robinson CV
    Biochem J; 2003 Oct; 375(Pt 2):323-8. PubMed ID: 12892563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses.
    Ashton AW; Boehm MK; Gallimore JR; Pepys MB; Perkins SJ
    J Mol Biol; 1997 Sep; 272(3):408-22. PubMed ID: 9325100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
    Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of pentameric human serum amyloid P component.
    Emsley J; White HE; O'Hara BP; Oliva G; Srinivasan N; Tickle IJ; Blundell TL; Pepys MB; Wood SP
    Nature; 1994 Jan; 367(6461):338-45. PubMed ID: 8114934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.
    Brown MR; Anderson BE
    J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein heterodimerization through ligand-bridged multivalent pre-organization: enhancing ligand binding toward both protein targets.
    Liu J; Zhang Z; Tan X; Hol WG; Verlinde CL; Fan E
    J Am Chem Soc; 2005 Feb; 127(7):2044-5. PubMed ID: 15713072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
    Hutchinson WL; Hohenester E; Pepys MB
    Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid P component forms a stable complex with human C5b6.
    Barbashov SF; Wang C; Nicholson-Weller A
    J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-assisted aggregation of proteins. Dimerization of serum amyloid P component by bivalent ligands.
    Ho JG; Kitov PI; Paszkiewicz E; Sadowska J; Bundle DR; Ng KK
    J Biol Chem; 2005 Sep; 280(36):31999-2008. PubMed ID: 16036920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component.
    Likó I; Mák M; Klement E; Hunyadi-Gulyás E; Pázmány T; Medzihradszky KF; Urbányi Z
    Neurosci Lett; 2007 Jan; 412(1):51-5. PubMed ID: 17141957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and SAP-like pentraxin are both present in Limulus polyphemus haemolymph: crystal structure of Limulus SAP.
    Shrive AK; Metcalfe AM; Cartwright JR; Greenhough TJ
    J Mol Biol; 1999 Jul; 290(5):997-1008. PubMed ID: 10438598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human serum amyloid P component from Pichia pastoris: production and characterization.
    Boysen S; Fogh-Schultz B; Andersen I; Højrup P; Iversen JJ; Wittenhagen P; Nielsen EH; Svehag SE
    Protein Expr Purif; 2004 Jun; 35(2):284-92. PubMed ID: 15135404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Ca2+, Mg2+, and heparin by human serum amyloid P component in affinity capillary electrophoresis.
    Heegaard NH; He X; Blomberg LG
    Electrophoresis; 2006 Jul; 27(13):2609-15. PubMed ID: 16817162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa.
    Malm J; Sonesson A; Hellman J; Bjartell A; Frohm B; Hillarp A
    Int J Androl; 2008 Sep; 31(5):508-17. PubMed ID: 17822421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
    Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
    Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.